TMCC3 expression based on
|
KIRP : Kidney renal papillary cell carcinoma
Comparison | Statistical significance |
Normal-vs-Primary | 4.36180003227093E-09 |
|
KIRP : Kidney renal papillary cell carcinoma Note
Cancer stage information is not available for 89 samples.
Show statistics |
Hide statistics |
Comparison |
Statistical significance |
Normal-vs-Stage1 |
4.42419999968635E-07 |
Normal-vs-Stage2 |
2.15299999999363E-05 |
Normal-vs-Stage3 |
3.86540000000268E-05 |
Normal-vs-Stage4 |
1.54360000004239E-07 |
Stage1-vs-Stage2 |
6.157400E-01 |
Stage1-vs-Stage3 |
4.957200E-01 |
Stage1-vs-Stage4 |
4.652400E-02 |
Stage2-vs-Stage3 |
8.861400E-01 |
Stage2-vs-Stage4 |
1.827820E-01 |
Stage3-vs-Stage4 |
2.665200E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma Note
Patient race information is not available for 15 samples and two samples from American Indians not included in the above plot.
Show statistics |
Hide statistics |
Comparison |
Statistical significance |
Normal-vs-Caucasian |
5.63520008434182E-10 |
Normal-vs-AfricanAmerican |
8.768300E-04 |
Normal-vs-Asian |
6.23989999999353E-05 |
Caucasian-vs-AfricanAmerican |
7.968300E-02 |
Caucasian-vs-Asian |
4.543200E-01 |
AfricanAmerican-vs-Asian |
1.956180E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma
Show statistics |
Hide statistics |
Comparison |
Statistical significance |
Normal-vs-Male |
1.04669994893669E-09 |
Normal-vs-Female |
3.160500E-04 |
Male-vs-Female |
1.468570E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma Note
Patient BMI information is not available for 72 samples.
Descriptions |
Normal weight |
BMI greater than equal to 18.5 and BMI less than 25 |
Extereme weight |
BMI greater than equal to 25 and BMI less than 30 |
Obese |
BMI greater than equal to 30 and BMI less than 40 |
Extreme Obese |
BMI greater than 40 |
Show statistics |
Hide statistics |
Comparison |
Statistical significance |
Normal-vs-Normal_Weight |
1.223740E-03 |
Normal-vs-Extreme_Weight |
2.77367018242103E-12 |
Normal-vs-Obese |
3.79390000000424E-05 |
Normal-vs-Extreme_Obese |
9.8511999999995E-05 |
Normal_Weight-vs-Extreme_Weight |
4.631700E-02 |
Normal_Weight-vs-Obese |
8.187400E-01 |
Normal_Weight-vs-Extreme_Obese |
4.746400E-01 |
Extreme_Weight-vs-Obese |
3.388100E-02 |
Extreme_Weight-vs-Extreme_Obese |
6.315000E-01 |
Obese-vs-Extreme_Obese |
5.233200E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma Note
Patient age information is not available for 3 samples.
Show statistics |
Hide statistics |
Comparison |
Statistical significance |
Normal-vs-Age(21-40Yrs) |
2.202699999998E-05 |
Normal-vs-Age(41-60Yrs) |
4.15279999999019E-06 |
Normal-vs-Age(61-80Yrs) |
6.01680039125085E-10 |
Normal-vs-Age(81-100Yrs) |
7.301700E-02 |
Age(21-40Yrs)-vs-Age(41-60Yrs) |
3.994000E-01 |
Age(21-40Yrs)-vs-Age(61-80Yrs) |
9.315400E-01 |
Age(21-40Yrs)-vs-Age(81-100Yrs) |
2.697000E-01 |
Age(41-60Yrs)-vs-Age(61-80Yrs) |
5.756000E-02 |
Age(41-60Yrs)-vs-Age(81-100Yrs) |
7.104000E-01 |
Age(61-80Yrs)-vs-Age(81-100Yrs) |
2.356600E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma NOTE
Histology information is not available for 17 samples.
Show statistics |
Hide statistics |
Comparison |
Statistical significance |
Normal-VS-Type1 PRCC |
3.88639997961349E-09 |
Normal-VS-Type2 PRCC |
1.618940E-04 |
Normal-VS-KIRP CIMP |
1.16399999972039E-07 |
Normal-VS-Unclassified PRCC |
1.584740E-03 |
Type1 PRCC-VS-Type2 PRCC |
6.612600E-01 |
Type1 PRCC-VS-KIRP CIMP |
1.518110E-02 |
Type1 PRCC-VS-Unclassified PRCC |
5.586000E-01 |
Type2 PRCC-VS-KIRP CIMP |
3.318500E-02 |
Type2 PRCC-VS-Unclassified PRCC |
9.068400E-01 |
KIRP CIMP-VS-Unclassified PRCC |
4.292000E-02 |
|
Histologic PRCC subtypes: Ricketts CJ et al, The Cancer Genome Atlas Comprehensive Molecular Characterization of Renal Cell Carcinoma. Cell Rep. 2018 Apr 3;23(1):313-326.e5. doi: 10.1016/j.celrep.2018.03.075
|
KIRP : Kidney renal papillary cell carcinoma Note
Nodal metastais status is not available for 1 sample and cancer in nearby lymph nodes cannot be measured (NX) in 211 samples.
pathologic_N descriptions |
N0 | No regional lymph node metastasis |
N1 | Metastases in 1 to 3 axillary lymph nodes |
N2 | Metastases in 4 to 9 axillary lymph nodes |
N3 | Metastases in 10 or more axillary lymph nodes |
Show statistics |
Hide statistics |
Comparison |
Statistical significance |
Normal-vs-N0 |
2.98150000244135E-08 |
Normal-vs-N1 |
2.29630000003755E-06 |
Normal-vs-N2 |
6.32619999999529E-05 |
N0-vs-N1 |
5.192000E-01 |
N0-vs-N2 |
2.841000E-01 |
N1-vs-N2 |
4.649400E-01 |
|
|